Volume 886, Issue 1

PharmacoEconomics & Outcomes News is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all PharmacoEconomics & Outcomes News articles

September 2021

September 4, 2021

38 articles in this issue

Adding normothermic machine perfusion to liver transplantation may be cost effective in Canada

Clinical study 04 September 2021 Pages: 1 - 1
Amyloid-PET not cost effective in patients with mild cognitive impairment in South Korea

Clinical study 04 September 2021 Pages: 2 - 2
Anlotinib appears to be cost effective as third- or further-line therapy for relapsed SCLC in China

Clinical study 04 September 2021 Pages: 3 - 3
Automatic respiratory rate monitoring may be cost effective for inpatients with pneumonia in the UK

Clinical study 04 September 2021 Pages: 4 - 4
Care manager in primary care setting highly cost effective for patients with depression in Sweden

Clinical study 04 September 2021 Pages: 5 - 5
Cerebral oedema large burden in US patients with large hemispheric infarction

Clinical study 04 September 2021 Pages: 6 - 6
COPD costs increase with severity and frequency of exacerbations

Clinical study 04 September 2021 Pages: 7 - 7
Cost effectiveness of UTI management strategies in the age of antibiotic resistance: urine culture with empirical antibiotics best strategy

Clinical study 04 September 2021 Pages: 8 - 8
Costs of treatments for liver cancer vary widely

Clinical study 04 September 2021 Pages: 9 - 9
Dienogest for endometriosis after surgery: better outcomes, lower cost

Clinical study 04 September 2021 Pages: 10 - 10
Estimating cost effectiveness of hepatitis B vaccination in US adults

Clinical study 04 September 2021 Pages: 11 - 11
Hula program cost effective in Hawaiians with hypertension

Clinical study 04 September 2021 Pages: 12 - 12
In long-term US cancer survivors, obesity is associated with substantial excess medical spending

Clinical study 04 September 2021 Pages: 13 - 13
Increasing cigarette tax in Iran would provide health and financial benefits to the poorest

Clinical study 04 September 2021 Pages: 14 - 14
Multi-cancer early detection blood test + current screening may be cost effective in the USA and UK

Clinical study 04 September 2021 Pages: 15 - 15
Primary care education on appropriate use criteria for paediatric TTE may save costs in the USA

Clinical study 04 September 2021 Pages: 16 - 16
Prophylactic factor IX therapy cost effective for children with haemophilia B in China

Clinical study 04 September 2021 Pages: 17 - 17
Reflex HCV RNA or antigen testing cost effective for HCV screening

Clinical study 04 September 2021 Pages: 18 - 18
Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany

Clinical study 04 September 2021 Pages: 19 - 19
Rifaximin cost effective in hepatic encephalopathy

Clinical study 04 September 2021 Pages: 20 - 20
Second-line therapy clinical trial participation cost saving for nSCLC patients in the USA

Clinical study 04 September 2021 Pages: 21 - 21
Sex, education level and employment status significantly affect WTP

Non-clinical study 04 September 2021 Pages: 22 - 22
Simplified one-stop HCV testing and confirmatory diagnosis cost effective in Iraq

Unknown 04 September 2021 Pages: 23 - 23
Single time-point AF screening does not appear to be cost effective in older patients in Germany

Clinical study 04 September 2021 Pages: 24 - 24
Tisagenlecleucel appears to be cost effective for diffuse large B-cell lymphoma in the USA

Clinical study 04 September 2021 Pages: 25 - 25
Urine-based biomarkers cost effective in guiding PCa biopsy decisions

Clinical study 04 September 2021 Pages: 26 - 26
User-testing of injectable medicines guidelines reduces errors and appears cost effective in the UK

Clinical study 04 September 2021 Pages: 27 - 27
Wearable cardioverter defribrillator use after ICD explantation may be cost saving for preventing SCD

Clinical study 04 September 2021 Pages: 28 - 28
Whole-genome sequencing cost effective in stage III/IV NSCLC?

Clinical study 04 September 2021 Pages: 29 - 29
ICER assessing plinabulin and trilaciclib for prevention of neutropenia

News item 04 September 2021 Pages: 30 - 30
ICER publishes draft scoping report on COVID-19 treatments

News item 04 September 2021 Pages: 31 - 31
ICER's observational real-world evidence update finds hereditary angioedema therapies less cost effective

News item 04 September 2021 Pages: 32 - 32
ICER's publishes final evidence report for atopic dermatitis therapies in the USA

News item 04 September 2021 Pages: 33 - 33
NICE pauses publication of updated ME/CFS guideline

News item 04 September 2021 Pages: 34 - 34
NICE publishes final guideline on routine care for pregnant women and their babies in the UK

News item 04 September 2021 Pages: 35 - 35
NICE: sapropterin now recommended for all pregnant women and young adults with PKU

News item 04 September 2021 Pages: 36 - 36
NZ's Pharmac to fund rosuvastatin with amended Special Authority criteria

News item 04 September 2021 Pages: 37 - 37
UK's NICE draft guidance recommends midostaurin for advanced systemic mastocytosis

News item 04 September 2021 Pages: 38 - 38

Volume 886, Issue 1

Search

Navigation